Language selection

Search

Patent 2383537 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2383537
(54) English Title: METHOD FOR MANUFACTURING FATTY ACID CALCIUM SALTS FROM HIGH GLYCERIDE CONTENT OILS
(54) French Title: METHODE DE FABRICATION DE SELS D'ACIDES GRAS ET DE CALCIUM A PARTIR D'HUILES RICHES EN GLYCERIDES
Status: Term Expired - Post Grant Beyond Limit
Bibliographic Data
(51) International Patent Classification (IPC):
  • C07C 51/41 (2006.01)
  • C11C 1/02 (2006.01)
  • C11C 1/04 (2006.01)
(72) Inventors :
  • STROHMAIER, GEORGE K. (United States of America)
  • FREDERIKSEN, EILER D. (United States of America)
  • LUCHINI, NESTOR DANIEL (United States of America)
(73) Owners :
  • VIRTUS NUTRITION LLC
(71) Applicants :
  • VIRTUS NUTRITION LLC (United States of America)
(74) Agent: OYEN WIGGS GREEN & MUTALA LLP
(74) Associate agent:
(45) Issued: 2006-09-05
(22) Filed Date: 2002-04-26
(41) Open to Public Inspection: 2002-09-19
Examination requested: 2002-06-21
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
09/990,784 (United States of America) 2001-11-14

Abstracts

English Abstract

A method for the preparation of fatty acid calcium salts, which includes the steps of (a) providing a fatty acid feedstock having a glyceride content between about 30 and about 60% by weight; (b) adding to the feedstock from about 2 to about 3 equivalents of calcium oxide relative to the feedstock, so that a reactive admixture is formed; and (c) adding to the reactive admixture from about 2 to about 5 equivalents of water relative to the calcium oxide so that the calcium oxide hydrates and neutralizes the fatty acids to form calcium salts. Fatty acid calcium salts containing eicosapentaenoic acid and decosahexaenoic acid are also disclosed, as well as methods for enhancing ruminant fertility.


French Abstract

Procédé pour la préparation de sels de calcium d'acides gras, incluant les étapes consistant à (a) fournir une matière de base d'acides gras ayant une teneur en glycéride comprise entre environ 30 et environ 60 % en poids ; (b) ajouter à la matière de base environ 2 à environ 3 équivalents d'oxyde de calcium par rapport à la matière de base, de sorte qu'un mélange réactif soit formé ; et (c) ajouter au mélange réactif environ 2 à environ 5 équivalents d'eau par rapport à l'oxyde de calcium de sorte que l'oxyde de calcium hydrate et neutralise les acides gras pour former des sels de calcium. Des sels de calcium d'acides gras contenant de l'acide éicosapentaénoïque et de l'acide décosahexaénoïque sont également divulgués, ainsi que des procédés pour stimuler la fertilité des ruminants.

Claims

Note: Claims are shown in the official language in which they were submitted.


15
WHAT IS CLAIMED IS:
1. ~A method for the preparation of fatty acid calcium salts comprising:
a) providing a fatty acid feedstock having a glyceride content
between about 30 and about 60 % by weight;
b) adding to said feedstock from about 2 to about 3 equivalents
of calcium oxide relative to said feedstock, so that a reactive admixture is
formed;
and
c) adding to said reactive admixture from about 2 to about 5
equivalents of water relative to said calcium oxide, so that said calcium
oxide
hydrates and neutralizes said fatty acids to form calcium salts,
wherein said feedstock is provided at a temperature at which said admixture
is uniform and liquid, and wherein said admixture and said water are not
heated.
2. ~The method of Claim 1, wherein said feedstock glycerides comprise fish
oils.
3. ~The method of Claim 2, wherein said feedstock comprises from about 15 to
about
50% by weight of fish oils.
4. ~The method of Claim 2, wherein said feedstock comprises from about 50 to
about
85% by weight of palm fatty acid distillate (PFAD).
5.~The method of Claim 2, wherein said fish oils are derived from one or more
fish
oil sources selected from the group consisting of menhaden, herring, mackerel,
caplin, tilapia,
tuna, sardine, pacific saucy and krill.

16~
6. The method of Claim 2, wherein said fish oil comprises from about 7 to
about 16%
by weight of decosahexaenoic acid (DHA) and from about 10 to about 17% by
weight of
eicosapentaenoic acid (EPA).
7. The method of Claim 1, wherein said fatty acid feedstock comprises from
about 50
to about 80% by weight of unsaturated fatty acids.
8. The method of Claim 1, wherein from about 2.25 to about 2.75 equivalents of
said
calcium oxide is employed.
9. The method of Claim 3, wherein said feedstock comprises from about 20 to
about
35% by weight of fish oil.
10. The method of Claim 3, further comprising the step of pre-treating said
fish oils to
reduce their glyceride content and increase the content of free fatty acids.
11. The method of Claim 10, wherein said step of pre-treating said fish oils
comprises
the step of pre-treating said fish oils with an enzyme that converts
glycerides to free fatty
acids.
12. The method of Claim 11, wherein said enzyme is a lipase.
13. The method of Claim 10, wherein said step of pre-treating said fish oils
comprises
hydrolyzing of said fish oil glycerides.

17
14. The method of Claim 1, further comprising the step of cooling said
admixture and
forming a solid, free-flowing and granular fatty acid calcium salt product.
15. A free-flowing fatty acid calcium salt prepared by the method of Claim 3,
and
having a glyceride content of less than about 5 weight percent, wherein said
fish oil has a
level of unsaturation of between about 50 and 95 weight percent.
16. A free-flowing fatty acid calcium salt product comprising from about 1 to
about
10% by weight of eicosapentaenoic acid (EPA) and from about 1 to about 10% by
weight of
decosahexaenoic acid (DHA), and having a residual glyceride content below
about 5 weight
percent.
17. The product of Claim 16, having a fatty acid profile consistent with a
profile
resulting from blending from about 15 to about 50% by weight of one or more
fish oils with
from about 85 to 50% by weight of palm fatty acid distillate (PFAD).
18. The product of Claim 17, wherein said fish oils are derived from one or
more fish
oil sources selected from the group consisting of menhaden, herring, mackerel,
caplin, tilapia,
tuna, sardine, pacific saury and krill.
19. A method for reducing the likelihood of embryonic death in a female
ruminant in the months following conception, comprising feeding said ruminant
an effective amount of the product of Claim 16 for at least 30 days after
conception.

18~
20. The method of Claim 19, wherein said female ruminant is a dairy cow.
21. The method of Claim 19, comprising starting the feeding of said product to
said
female ruminant between about 21 days before and about 28 days after
parturition.
22. The method of Claim 19, wherein said product is fed to said female
ruminant
daily.
23. The method of Claim 19, wherein said product is fed to said female
ruminant for
at least 60 days after conception.
24. The method of Claim 19, wherein said product is fed to said female
ruminant for
at least 150 days after conception.
25. The method of Claim 19, wherein the feeding of said product comprising
EPA and DHA is discontinued within 150 days after conception and said method
further
includes the step of feeding daily to said female ruminant a fatty acid
calcium salt product
for supplying milk production energy to a female ruminant after the feeding of
said
product comprising EPA and DHA is discontinued.

19
26. A method for increasing fertility in a female ruminant, comprising
feeding said ruminant, starting between 21 days before and 28 days after
parturi-
tion, an effective amount of the product of claim 16.
27. The method of Claim 26, wherein the fatty acids of said fatty acid
calcium salts have a fatty acid profile consistent with a profile resulting
from
blending from about 15 to about 50% by weight of one or more fish oils with
from
about 85 to 50 % by weight of palm fatty acid distillate.
28. The method of Claim 27, wherein said fish oils are derived from one
or more fish oil sources selected from the group consisting of menhaden,
herring,
mackerel, caplin, tilapia, tuna, sardine, pacific saucy and krill.
29. The method of Claim 26, wherein said female ruminant is a dairy
cow.
30. The method of Claim 26, wherein said product is fed to said female
ruminant daily.
31. The method of Claim 26, wherein said feeding of said product to said
female ruminant is continued for a period of time following conception.
32. The method of Claim 31, wherein said product is fed to said female
ruminant for at least 30 days after conception.
33. The method of Claim 32, wherein said product is fed to said female
ruminant for at least 60 days after conception.
34. The method of Claim 33, wherein said product is fed to said female
ruminant for at least 150 days after conception.
35. The method of Claim 26, wherein the feeding of said product comprising
EPA and DHA is continued for a period of time following conception, but not
longer than
150 days following conception and said method further includes the step of
feeding daily
to said female ruminant a fatty acid calcium salt product for supplying milk
production
energy to a female ruminant after the feeding of said product comprising EPA
and DHA
is discontinued.

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02383537 2002-04-26
10
METHOD FOR MANUFACTURING
FATTY ACID CALCIUM SALTS
FROM HIGH GLYCERIDE CONTENT OILS
BACKGROUND OF THE INVENTION
The present invention relates to a process for the production of rumen bypass
feed
supplements. The process converts glyceride oils to their respective fatty
acid calcium salts.
In particular, the present invention relates to a process for the production
of calcium salts of
unsaturated fatty acids derived from fish oil. The calcium salts of the
present invention,
when fed to cattle, provide reproductive benefits, in particular, an increase
in fertility as
embodied in an increased rate of impregnation. The present invention therefore
also relates
to methods for providing such benefits in a ruminant.
Dairy cows must be impregnated once a year to maintain a lactation cycle in
which
milk is produced for ten months at a time with two month rest periads in
between during
which the cow is dry. Given the gestation period of a dairy cow, the objective
is to
impregnate the cow within 83 days after calving. The effcient management of a
dairy herd
thus requires that the cows be maintained at the peak of fertility to ensure
re-impregnation
within 83 days.

CA 02383537 2002-04-26
2
Accordingly, there exists a need for nutritional supplements that promote
dairy cow
fertility. Fish oil fatty acids have become the focus of numerous research
programs that seek
to capitalize on their nutritional and physiological properties. WO 99/66877
discloses the
use of omega-3 fatty acids of fish oil origin to increase fertility in animals
including cattle.
Among the omega-3 fatty acids disclosed are eicosapentaenoic acid (EPA) and
decosahexaenoic acid (DHA).
Unsaturated fatty acids, however, undergo hydrogenation to saturated fatty
acids by
microbial action in the rumen and must be fed to ruminants in a protected
form. The most
familiar form in which fatty acids in general are protected from microbial
action in the rumen
are the fatty acid calcium salts disclosed by U.S. Patent Nos. 4,642,317;
4,826,694,
4,853,233; 4,853,233 and 4,909,138. This form of fatty acid protection is
widely accepted in
the dairy industry.
Fish oils have a glyceride content of 100%. That is, all of the fatty acids in
fish oils
are in the glyceride form. Fariy acid glycerides do not readily react to form
calcium salts
using the processes disclosed by the above-listed patents. For a product to be
commercially
feasible, glyceride levels below about S weight percent are desirable to
produce a free-
flowing and stable product.
U.S. Patent No. 5,382,678 discloses a process that reportedly can be used to
prepare
fatty acid calcium salts from feedstocks having glyceride contents as high as
40 weight
percent, with the resulting product having a residual glyceride content of
less than about 5
weight percent. Products with residual glyceride contents above 5 weight
percent lack
storage stability, and are susceptible to oxidation, post-heating, melting,
subsequent product
solidification, and a tendency to fonm lumps upon storage. Under industrial
conditions,
however, it has not been possible to consistently obtain residual glyceride
levels below 5

CA 02383537 2002-04-26
3
weight percent once the initial glyceride content of the fatty acid feed stock
is above about 25
weight percent when using the process of U.S. Patent No. 5,382,678.
Hydrolyzing the glycerides to levels below 25 weight percent is not
commercially
feasible. Commercial omega-3 fatty acids in the free fatty acid form are so
costly as to be
commercially unfeasible. One can reduce the glyceride content of the fish oil
starting
material by blending it with a low glyceride content fatty acid feedstock,
such as Palm Fatty
Acid Distillate (PFAD), which has a glyceride content of about 15 to 20 weight
percent.
However, the quantity of PFAD that would have to be added to fish oil to
reduce the
glyceride content to levels commercially feasible for use with the process of
U.S. Patent No.
5,382,678 dilutes the concentration of desirable omega-3 fatty acid such as
EPA and DHA to
ineffective levels. That is, the levels of DHA and EPA in the resulting
calcium salt are so
low that quantities of calcium salt must be added to the daily feed ration at
levels above what
is considered acceptable by the dairy industry.
To be commercially viable, omega-3 fatty acid calcium salt feed supplements
must
1 S have DHA and EPA concentrations high enough to confer the beneficial
effects of these
omega-3 fatty acids when quantities of the calcium salt are added to feed
ration at levels
considered acceptable to the cattle industry. Therefore, a need exists for a
process by which
calcium salts may be prepared from fish oils having high concentrations of
omega-3 fatty
acid with the calcium salts produced with reduced levels of unreacted
glycerides in a free-
flowing and stable form easily handled by customers.

CA 02383537 2003-09-29
A
SUIlMMARY OF THE INVENTION
This need is met by the present invention. It has now been discovered that
fatty acid
calcium salts having acceptable levels of residual glycerides can be prepared
from high
glyceride content starting materials by using elevated levels of calcium
oxide, making it
possible to prepare fatty acid calcium salts from feedstocks containing levels
of fish oil
effective to provide useful concentrations of omega-3 fatty acids in the
finished product.
Therefore, according to one aspect of the present invention, a method is
provided for
the preparation of fatty acid calcium salts, which includes the steps of
(a) providing a fatty acid feedstock having a glyceride content between about
30
and about 60% by weight;
(b) adding to the feedstock from about 2 to about 3 equivalents of calcium
oxide
relative to the feedstock, so that a reactive admixture is formed; and
(c) adding to the reactive admixture from about 2 to about 5 equivalents of
water
relative to the calcium oxide, so that the calcium oxide hydrates and
neutralizes the fatty
acids to form calcium salts.
The method of the present invention thus includes the use of feedstocks
derived from
fish oils diluted to glyceride contents between about 30 and about 60 weight
percent with low
glyceride content fatty acid feedstocks, such as PFAD. Other suitable sources
of low
glyceride content fatty acids include fatty acids from soy, cottonseed, corn
and other
vegetable fatty acid distillates, tallov~~, yellow grease or other animal or
fish derived free fatty
acid sources produced by deodorization, refining, hydrolyzation or other
processes common
in the fats and oil industry.
In one embodiment, the method of the present invention further comprises

CA 02383537 2003-09-29
4a
cooling the admixture to form a solid, free-flowing and granular fatty acid
calcium salt
product.
15

CA 02383537 2003-09-29
Thus, the method of the present invention obtains fatty acid calcium salts
having
useful concentration of omega-3 fatty acids and acceptable levels of residual
glycerides that
heretofore could not be obtained on a commercial scale using prior art
manufacturing
techniques. Therefore, according to another aspect of the present invention,
fatty acid
calcium salts are provided containing omega-3 fatty acids and residual
glyceride levels below
about 5 weight percent that are prepared by the method of the present
invention. More
specifically, a fatty acid calcium salt product is provided having a residual
glyceride content
below about S weight percent and containing from about 1 to about 10% by
weight of EPA
calcium salt and from about 1 to about 10% by weight of DHA calcium salt.
The DHA-and EPA- containing fatty acid calcium salts enhance the fertility of
ruminants without using 100% glyceride content fish oil feedstocks. That is,
beneficial
results are obtained from feedstocks blended with fatty acids from sources
other than fish
oils.
Therefore, according to still yet another aspect of the present invention, a
method is
1 ~ provided for increasing fertility in a ruminant, in which the ruminant is
fed an effective
amount of the EPA- and DHA- containing fatty acid calcium salts of the present
invention.
The method of the present invention is particularly effective to enhance the
fertility of female
ruminants, especially dairy cows. Methods in accordance with the present
invention begin
feeding the supplements daily to a female ruminant from about 21 days before
to about 28
days after parturition and feeding continue at least until conception occurs.
The fertility
enhancement obtained by the calcium salts of the present invention also
includes a reduction
in ernbr~~onic death in the months fbllowing conception. Therefore, methods in
accordance
wfith the present invention continue feeding the supplements to a female
ruminant for at least
da~~s, and preferably for at least 60 days after conception.

CA 02383537 2003-09-29
Sa
In one further embodiment of the invention, the feeding of the product
comprisingEPA
and DHA is discontinued at conception or within 150 days thereafter and the
method further
includes the step of feeding daily to a female ruminant a fatty acid calcium
salt product for
supplyingmilk energy to a female ruminant after the feeding of the product
comprising EPA and
DHA is discontinued.

CA 02383537 2002-04-26
6
The above and other features and advantages of the present invention will
become
clear from the following description of the preferred embodiment.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
The present invention provides a process by which high glyceride content fatty
acid
feedstocks may be converted to free-flowing powder or granular fatty acid
calcium salt
rumen bypass feed supplements, making it possible to prepare fatty acid
calcium salts from
fish oils, wherein the calcium salts contain useful and beneficial quantities
of omega-3 fatty
acids. The use of such high glyceride content fatty acid feedstocks represents
a significant
departure from conventional processes for the manufacture of fatty acid
calcium salt feed
supplements. The term "glyceride" as employed herein includes Cip-C22 fatty
acid
monoglycerides, diglycerides, triglycerides, and any mixture thereof.
In a typical process according to the present invention, fatty acid feedstocks
are added
1 S to a production vessel. The mixing should be accomplished in a kettle
designed so that
intensive and intimate contacting occurs between the calcium oxide and fat/oil
admixture so
that a homogeneous dispersion of the calcium oxide particles results. The
types of internal
mixing elements span a wide gap but would include those with propeller,
turbine, plows with
chopper blades, or preferably "Cowles-type" dispersing blades as examples, but
others may
apply. These same devices would also be suitable for dispersing and
homogenizing the water
fraction into the fat/oil-calcium oxide admixture.
Fatty acid feedstocks are employed containing up to about 60 weight percent of
the
fatty acid content in the form of fatty acid glycerides. Glyceride levels
between about 30 and
about 60 weight percent are preferred.

CA 02383537 2002-04-26
7
Suitable feedstocks include essentially any glyceride or glyceride derivative
having a
fatty acid profile determined to be nutritionally or physiologically
beneficial to a ruminant.
Beneficial fatty acid profiles are readily identified by those of ordinary
skill in the art, and
may be derived from any known source, inclusive of fatty acid sources of
animal, vegetable
or fish origin. This includes distillates and soap stocks of lard or tallow,
vegetable oils such
as canola oil, sunflower oil, safflower oil, rapeseed oil, soy bean oil, olive
oil, corn oil, palm
oil, and the like, and byproducts thereof, as well as fish oils and byproducts
thereof.
Such fatty acid feedstocks typically contain from about 10 to about 100 weight
percent of the fatty acid content in the form of fatty acid glycerides, from
about 0 to about
90% by weight of free fatty aids, and less than 5% by weight of moisture,
insolubles and
unsaponifiables. When necessary, the glyceride content may be reduced to about
60% by
weight and lower by adding fatty acid distillates such as PFAD to the
feedstock or by
pre-treatment to convert a portion of the glycerides to free fatty acids,
either catalytically
through the use of enzymes, including lipases, or by hydrolysis. Pre-treatment
processes may
also include processes that increase the level of desirable fatty acids, for
example, cold
acetone extraction may be used to increase the level of EPA and D:HA in fish
oil.
The present invention thus makes possible the preparation of fatty acid
calcium salts
from fish oils, which have a 100% glyceride content. According to one
embodiment of the
present invention, from about 15 to about 50 weight percent of fish oil is
blended with from
about 85 to about 50 weight percent of a fatty acid feedstock sufficiently low
in glyceride
content to provide a blend with a glyceride content of less than about 60% by
weight. Blends
of fish oils with PFAD within these weight ratios are included within the
scope of the present
invention. A blend containing from about 20 to about 35% by weight of fish oil
is preferred.

CA 02383537 2002-04-26
g
The process of the present invention is particularly well suited for the
preparation of
fatty acid calcium salts containing beneficial levels of DHA and EP.A from
fatty acid
feedstocks containing high levels of fish oil. Oils containing from about 7 to
about 16% by
weight DHA and from aboutl0 to about 17% by weight EPA are preferred.
The feedstock may also contain up to about 95% by weight of unsaturated C:16-
C:22
fatty acids. Unsaturated fatty acid levels between 50 and about 80 weight
percent are
preferred. In general, unsaturated fatty acids having from 16 to 22 carbon
atoms and from 1
to 6 double bonds are suitable for use with the present invention.
Polyunsaturated fatty acids
are preferred, with examples of desirable polyunsaturated fatty acids
including fish oil-
derived omega-3 and omega-6 fatty acids. Suitable fish oil sources include
menhaden,
herring, mackerel, caplin, tilapia, tuna, sardine, pacific saury, krill, and
the like.
It may be necessary to heat the fatty acid feedstock to form a uniform, liquid
admixture, depending upon the degree of saturation. A temperature up to about
175 °F is
suitable, with a temperature between about 120 and about 140°F being
preferred.
Calcium oxide is added to the fatty acid feedstock in the range from about 2
to about
3 equivalents relative to the fatty acid feedstock. A calcium oxide level
between about 2.25
and 2.75 equivalents is preferred.
Water is then added to hydrate the calcium oxide to its hydroxide form,
creating a
large amount of exothermic heat. The heat that is evolved usually is
sufficient for the fatty
acid neutralization reaction to proceed to completion, so that it is not
necessary to supply heat
to the reaction mixture. Between about 2 and about 5 equivalents of water
relative to the
calcium oxide is added to the reaction mixture, with between about 2.5 and
about 3.5
equivalents being preferred.

CA 02383537 2002-04-26
9
The excess water is converted to steam by the exothermic heat generated and
boils off
rapidly. The reaction can be performed under atmospheric pressure, or under
vacuum to
draw off the steam.
The amount of time required for the reaction is between about 5 and about 60
minutes, and more typically between about 6 and about 15 minutes. The reaction
is easily
identified by the transformation of the admixture into a solid granular mass.
Upon transfer
from the reaction vessel, it can easily be processed into dry free-flowing
particles.
Fish oil derived fatty acid calcium salt rumen bypass feed supplements of the
present
invention have a residual glyceride content below about 5 weight percent and
contain from
about 1 to about 10% by weight EPA calcium salt and from about 1 to about
10% by weight DHA calcium salt. Products containing from about 1.5 to about 9%
by
weight of EPA and DHA are preferred. The EPA- and DHA- containing feed
supplements
derived from fish oil/PFAD blends enhance the fertility of female ruminants.
The present
invention makes possible the commercially viable preparation of DHA- and EPA-
rich
calcium salt feed supplements for the enhancement of female ruminant
fertility.
The present invention therefore includes fatty acid calcium salts having a
fatty acid
profile consistent with a profile resulting from blending from about 15 to
about 50% by
weight of fish oil with from about 85 to about 50% by weight of PFAD, wherein
the fatty
acid profile includes from about 1 to about 10% by weight of DHA and from
about 1 to about
10% by weight of EPA.
The fatty acid calcium salt rumen inert feed supplements of the present
invention may
be conveniently fed to a ruminant admixed with a conventional ruminant feed.
The feeds are
typically vegetable materials edible by ruminants, such as legume hay, grass
hay, corn silage,
grass silage, legume silage, corn grain, oats, barley, distiller's grain,
brewer's grain, soya

CA 02383537 2002-04-26
bean meal and cottonseed meal. There is no particular lower limit of the
calcium salt to be
added to the ruminant feed, although in practice, amounts of the calcium salt
below an
amount that supplies 6 grams per day each of DHA and EPA are too small to
provide
significant fertility enhancement.
The fertility of female ruminants is enhanced when they are fed the EPA- and
DHA-
containing calcium salts starting as early as 21 days before parturition.
While useful
enhancement of fertility may be obtained by starting dietary supplementation
at parturition or
as late as 28 days following parturition, optimal results are obtained by
earlier
supplementation.
The dietary supplementation should continue daily at least until conception.
However, because the DHA- and EPA- containing calcium salts of the present
invention also
enhance fertility by reducing embryonic death in the months following
conception, the
present invention also includes methods in which dietary supplementation is
continued for at
least 30 days and preferably for at least 60 days after conception. Beneficial
results are
obtained when dietary supplementation is continued up to 150 days after
conception.
The DHA- and EPA- containing calcium salts of the present invention may be
co-administered with additional quantities of other fatty acid calcium salts
that are fed to
ruminants for other purposes. The DHA- and EPA- containing calcium salts may
be
co-administered with a fatty acid calcium salt intended to supply energy to a
high milk
production ruminant, with a calcium salt having a fatty acid profile selected
to modify the
fatty acid profile of the milk fat or meat fat of the ruminant, or with both.
Accordingly, the
methods of the present invention for enhancing female ruminant fertility do
not exclude the
co-administration of other fatty acid calcium salt that do not contain DHA or
EPA. One
method in accordance with the present invention transitions the ruminant from
the DHA- and

CA 02383537 2002-04-26
11
EPA- containing calcium salts of the present invention to fatty acid calcium
salts intended to
supply energy to a high milk production ruminant once the fertility-enhancing
benefits of the
DHA- and EPA- containing calcium salts are no longer needed.
The following non-limiting examples set forth herein below illustrate certain
aspects
of the invention. All parts and percentages are by weight unless otherwise
noted, and all
temperatures are in degrees Fahrenheit.
EXAMPLES
Example 1
190 kg of calcium oxide was added to a vertical mixer (with "Cowles-type"
dispensing blades) containing a blend of 190 kg of menhaden fish oil (Omega
Protein,
Hammond, LA) and 740 kg PFAD. The fish oil had by concentration 15.7% by
weight DHA
and 11.7% by weight EPA. The total glyceride content was approximately 35
weight
percent. Prior to adding the calcium oxide, the fish oil/PFAD blend was heated
to a
temperature of 130°F. After the calcium oxide was uniformly dispersed
(approximately 2
minutes) 204 kg of water was added, producing an exothermic reaction that
heated the
temperature of the mixture to between 160 and 170°F. Agitation
continued until a uniform,
homogenous mixture was obtained, which was dumped from the vessel into a tray,
after
which the reaction went to completion in a 210 to 240°F over-boil. The
product was then
permitted to cool. Milling of the finished product produced a free-flowing
granule that was
not dusty having an unreacted glyceride content of less than 4% by weight. The
total fat
content was about 82% by weight, including DHA and EPA.

CA 02383537 2002-04-26
12
Exam lep s 2-6
Example 1 was repeated using the following quantities of water, calcium oxide,
fish
oil and PFAD:
EXAMPLE 2 3 4 5 6
Water 180 kg 180 kg 180 kg 180 kg 180 kg
Ca0 180 190 180 180 186
Fish Oil 190 190 190 190 186
PFAD 740 750 750 750 750
Free-flowing granules were obtained that were not dusty and had an unreacted
glyceride content of less than 5% by weight. Fat content ranged between 81 and
84% by
weight, which included DHA and EPA.
The following examples demonstrate enzyme pre-treatment processes to reduce a
portion of the glyceride content of fish oils:
Example 7
Dry fungal-derived lipase was tested and found to have a lipase activity level
of
150,000 FIP/gram concentration. A lipase mixture was prepared by blending
13.3% by
weight of the dry lipase with a 10% by weight gum arabic emulsifier solution.
Peruvian
Crude Fish Oil was processed with the lipase mixture at a 10% weight ratio of
lipase mixture
to fish oil, corresponding to 1.33% by weight dry lipase being added to the
fat mixture. The
mixture was allowed to react for 18 hours at 104°F. At the end of the
18 hours, 67 grams of
the lipase treated fish oil was blended with 140 grams PFAD and reacted with
40 grams of

CA 02383537 2002-04-26
13
calcium oxide and 38 grams of water to convert the mixture to a calcium salt
according to the
procedure described in Example 1.
The product that resulted had less than 5% of the glyceride content remaining
as
unreacted fat. The resulting calcium salts were a dry free-flowing powder.
Example 8
Example 7 was repeated using a yeast-derived lipase having an activity of
200,000
FIP/gram in a quantity corresponding to 1 % dry lipase being added to the fish
oil.
The product that resulted contained less than S% of the glyceride content
remaining
as unreacted fat. The resulting calcium salts were a dry free-flowing powder.
Examine 9
Example 7 was repeated using a commercial liquid lipase in a propylene glycol
diluent. It was added at 10% by weight of the fish oil for treatment under the
same
time/temperature conditions.
The product that resulted contained less than 5% of the glyceride content
remaining
as unreacted fat. The resulting calcium salts were a dry free-flowing powder.
The present invention thus provides rumen-protected fatty acid calcium salts
rich in
DHA and EPA for enhancement of ruminant fertility. The present invention also
provides a
method for the preparation of these products in a form familiar to and
accepted by the dairy
and cattle industry.
The foregoing examples and description of the preferred embodiment should be
taken
as illustrating, rather than as limiting, the present invention as defined by
the claims. As will
be readily appreciated, numerous combinations of the features set forth above
can be utilized

CA 02383537 2002-04-26
14
without departing from the present invention as set forth in the claims. Such
variations are
not regarded as a departure from the spirit and scope of the invention, and
all such
modifications are intended to be included within the scope of the following
claims.
15

Representative Drawing

Sorry, the representative drawing for patent document number 2383537 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: Expired (new Act pat) 2022-04-26
Inactive: Office letter 2020-07-03
Inactive: COVID 19 - Deadline extended 2020-05-28
Inactive: COVID 19 - Deadline extended 2020-05-14
Inactive: COVID 19 - Deadline extended 2020-04-28
Inactive: COVID 19 - Deadline extended 2020-03-29
Common Representative Appointed 2019-10-30
Common Representative Appointed 2019-10-30
Inactive: Late MF processed 2016-05-18
Letter Sent 2016-04-26
Inactive: IPC expired 2016-01-01
Inactive: IPC expired 2016-01-01
Inactive: IPC expired 2016-01-01
Inactive: IPC expired 2016-01-01
Inactive: IPC removed 2012-09-27
Inactive: IPC removed 2012-09-27
Inactive: IPC removed 2012-09-27
Inactive: Late MF processed 2012-05-29
Letter Sent 2012-04-26
Inactive: Late MF processed 2009-08-19
Letter Sent 2009-04-27
Letter Sent 2006-11-29
Inactive: Single transfer 2006-11-01
Grant by Issuance 2006-09-05
Inactive: Cover page published 2006-09-04
Pre-grant 2006-06-16
Inactive: Final fee received 2006-06-16
Inactive: IPC from MCD 2006-03-12
Inactive: IPC from MCD 2006-03-12
Inactive: IPC from MCD 2006-03-12
Inactive: IPC from MCD 2006-03-12
Inactive: IPC from MCD 2006-03-12
Inactive: IPC from MCD 2006-03-12
Inactive: IPC from MCD 2006-03-12
Notice of Allowance is Issued 2006-01-17
Letter Sent 2006-01-17
Notice of Allowance is Issued 2006-01-17
Inactive: Approved for allowance (AFA) 2006-01-05
Amendment Received - Voluntary Amendment 2005-11-02
Inactive: S.30(2) Rules - Examiner requisition 2005-05-17
Amendment Received - Voluntary Amendment 2005-04-20
Inactive: S.30(2) Rules - Examiner requisition 2004-12-20
Inactive: S.29 Rules - Examiner requisition 2004-12-20
Amendment Received - Voluntary Amendment 2004-08-18
Inactive: S.30(2) Rules - Examiner requisition 2004-02-18
Inactive: S.29 Rules - Examiner requisition 2004-02-18
Amendment Received - Voluntary Amendment 2004-02-11
Letter Sent 2003-10-16
Reinstatement Request Received 2003-09-29
Reinstatement Requirements Deemed Compliant for All Abandonment Reasons 2003-09-29
Inactive: Abandoned - No reply to s.30(2) Rules requisition 2003-06-05
Inactive: S.30(2) Rules - Examiner requisition 2002-12-05
Inactive: First IPC assigned 2002-09-20
Application Published (Open to Public Inspection) 2002-09-19
Inactive: Cover page published 2002-09-18
Letter sent 2002-08-08
Letter Sent 2002-08-08
Advanced Examination Determined Compliant - paragraph 84(1)(a) of the Patent Rules 2002-08-08
Early Laid Open Requested 2002-07-12
Inactive: Advanced examination (SO) fee processed 2002-07-12
Inactive: Advanced examination (SO) 2002-07-12
Inactive: First IPC assigned 2002-06-21
Request for Examination Requirements Determined Compliant 2002-06-21
All Requirements for Examination Determined Compliant 2002-06-21
Request for Examination Received 2002-06-21
Inactive: IPC assigned 2002-06-21
Inactive: IPC assigned 2002-06-21
Inactive: IPC assigned 2002-06-21
Inactive: Filing certificate - No RFE (English) 2002-06-05
Filing Requirements Determined Compliant 2002-06-05
Letter Sent 2002-06-05
Letter Sent 2002-06-05
Letter Sent 2002-06-05
Letter Sent 2002-06-05
Application Received - Regular National 2002-06-05

Abandonment History

Abandonment Date Reason Reinstatement Date
2003-09-29

Maintenance Fee

The last payment was received on 2006-04-18

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
Application fee - standard 2002-04-26
Registration of a document 2002-04-26
Request for examination - standard 2002-06-21
Advanced Examination 2002-07-12
Reinstatement 2003-09-29
MF (application, 2nd anniv.) - standard 02 2004-04-26 2004-04-08
MF (application, 3rd anniv.) - standard 03 2005-04-26 2005-04-15
MF (application, 4th anniv.) - standard 04 2006-04-26 2006-04-18
Final fee - standard 2006-06-16
Registration of a document 2006-11-01
MF (patent, 5th anniv.) - standard 2007-04-26 2007-03-16
MF (patent, 6th anniv.) - standard 2008-04-28 2008-04-11
MF (patent, 7th anniv.) - standard 2009-04-27 2009-08-19
Reversal of deemed expiry 2016-04-26 2009-08-19
MF (patent, 8th anniv.) - standard 2010-04-26 2010-04-19
MF (patent, 9th anniv.) - standard 2011-04-26 2011-03-09
MF (patent, 10th anniv.) - standard 2012-04-26 2012-05-29
Reversal of deemed expiry 2016-04-26 2012-05-29
MF (patent, 11th anniv.) - standard 2013-04-26 2013-03-14
MF (patent, 12th anniv.) - standard 2014-04-28 2014-03-12
MF (patent, 13th anniv.) - standard 2015-04-27 2015-04-01
MF (patent, 14th anniv.) - standard 2016-04-26 2016-05-18
Reversal of deemed expiry 2016-04-26 2016-05-18
MF (patent, 15th anniv.) - standard 2017-04-26 2017-04-05
MF (patent, 16th anniv.) - standard 2018-04-26 2018-04-04
MF (patent, 17th anniv.) - standard 2019-04-26 2019-04-03
MF (patent, 18th anniv.) - standard 2020-04-27 2020-05-20
MF (patent, 19th anniv.) - standard 2021-04-26 2021-03-31
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
VIRTUS NUTRITION LLC
Past Owners on Record
EILER D. FREDERIKSEN
GEORGE K. STROHMAIER
NESTOR DANIEL LUCHINI
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Description 2003-09-29 16 589
Claims 2003-09-29 5 121
Description 2002-04-26 14 579
Claims 2002-04-26 5 119
Abstract 2002-04-26 1 19
Cover Page 2002-08-26 1 33
Claims 2004-08-18 5 150
Claims 2005-04-20 5 157
Cover Page 2006-08-08 1 36
Courtesy - Certificate of registration (related document(s)) 2002-06-05 1 114
Courtesy - Certificate of registration (related document(s)) 2002-06-05 1 114
Courtesy - Certificate of registration (related document(s)) 2002-06-05 1 114
Courtesy - Certificate of registration (related document(s)) 2002-06-05 1 114
Filing Certificate (English) 2002-06-05 1 165
Acknowledgement of Request for Examination 2002-08-08 1 193
Courtesy - Abandonment Letter (R30(2)) 2003-08-14 1 167
Notice of Reinstatement 2003-10-16 1 167
Reminder of maintenance fee due 2003-12-30 1 110
Commissioner's Notice - Application Found Allowable 2006-01-17 1 161
Courtesy - Certificate of registration (related document(s)) 2006-11-29 1 105
Maintenance Fee Notice 2009-06-08 1 171
Late Payment Acknowledgement 2009-09-11 1 164
Maintenance Fee Notice 2012-05-29 1 172
Late Payment Acknowledgement 2012-05-29 1 165
Late Payment Acknowledgement 2012-05-29 1 165
Maintenance Fee Notice 2016-05-18 1 170
Late Payment Acknowledgement 2016-05-18 1 163
Late Payment Acknowledgement 2016-05-18 1 163
Correspondence 2002-07-12 1 47
Correspondence 2006-06-16 1 35